SCHEMBL13489644

SCHEMBL13489644

Cc1cccc(Cl)c1OC(C)(C)C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.45
GAA P10253 2/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HTR1A P08908 2/20 0.36
SLC6A2 P23975 1/20 0.36
HSP90AA1 P07900 1/20 0.35
PDK1 Q15118 1/20 0.35
PDK2 Q15119 1/20 0.35
PDK3 Q15120 1/20 0.35
PDK4 Q16654 1/20 0.35
ALDH1A1 P00352 1/20 0.34
POLB P06746 2/20 0.34
HTR2A P28223 2/20 0.34
HTR2B P41595 2/20 0.34
HTR2C P28335 1/20 0.34
SCN4A P35499 3/20 0.33
CYP2D6 P10635 2/20 0.33
LMNA P02545 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13020125 0.87 KMT2A (0.38) KDM4EL3MBTL1HTR1APDK1PDK2
SCHEMBL16170099 0.84 SCN4A (0.43) KDM4EALDH1A1HTR2AHTR2BSCN4A
SCHEMBL16957704 0.82 KDM4E (0.44) KDM4EGAAMAPTRAB9AL3MBTL1
SCHEMBL4004810 0.81 KCNH2 (0.39) MAPTRAB9AHTR1ASLC6A2HSP90AA1
SCHEMBL3789902 0.81 L3MBTL1 (0.39) KDM4EGAAL3MBTL1HTR1ASLC6A2
SCHEMBL3789699 0.78 ALDH1A1 (0.47) GAAHTR1AALDH1A1POLBKMT2A
SCHEMBL16447989 0.77 KDM4E (0.44) KDM4EGAAMAPTRAB9AL3MBTL1
SCHEMBL30373634 0.76 POLB (0.46) KDM4EL3MBTL1PDK1PDK2PDK3
SCHEMBL14985358 0.76 KDM4E (0.49) KDM4EGAAMAPTRAB9AL3MBTL1
SCHEMBL3236165 0.76 RAB9A (0.50) KDM4EGAAMAPTRAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029648-A1 11-Beta HSD1 Inhibitors XIANG JASON SHAOYUN 2010-02-04 US disclosed
US-7632838-B2 11-beta HSD1 inhibitors WYETH (US) 2009-12-15 US disclosed
US-20070219198-A1 11-Beta HSD 1 inhibitors WYETH (US) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029648-A1 11-Beta HSD1 Inhibitors HSD11B1, HSD3B1, HSD11B2 KDM4E 1296/4885GAA 2353/4885MAPT 3352/4885
US-20070219198-A1 11-Beta HSD 1 inhibitors HSD11B1, HSD11B2, HSD3B1 KDM4E 1360/4885GAA 2688/4885MAPT 3097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.